Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Genet Mol Res ; 12(4): 6611-8, 2013 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-24391007

RESUMEN

In order to better understand vitamin D3 in cattle metabolism, we quantified 1alpha-HYD and 24-HYD gene expression. In the kidneys of 35 male Nellore cattle, these were divided into a control group and two treatment groups (2 x 10(6) international units of vitamin D3 administered for 2 or 8 consecutive days pre-slaughter). Vitamin D3 supplementation resulted in a significant increase in 1alpha-HYD gene expression; however, significantly increased 24-HYD gene expression was only detected in cattle that had 8 days of supplementation. The finding of upregulation of 24-HYD due to vitamin D supplementation is in line with the expected rise in 24,25-di-hydroxy-vitamin D3 synthesis observed when plasma vitamin D3 concentrations are high, stimulating excretion by the organism. On the other hand, upregulation of 1alpha-HYD was unexpected, since vitamin D3 supplementation has been reported to impact these two genes in opposite directions. We conclude that vitamin D3 metabolism in these animals is more complex than previously reported.


Asunto(s)
25-Hidroxivitamina D3 1-alfa-Hidroxilasa/biosíntesis , Bovinos/metabolismo , Colecalciferol/farmacología , Riñón/metabolismo , Esteroide Hidroxilasas/biosíntesis , 25-Hidroxivitamina D3 1-alfa-Hidroxilasa/genética , Animales , Calcio/sangre , Suplementos Dietéticos , Exposición a Riesgos Ambientales , Expresión Génica , Gliceraldehído 3-Fosfato Deshidrogenasa (NADP+)/biosíntesis , Masculino , Carne , Factor 1 de Elongación Peptídica/biosíntesis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Proteínas Ribosómicas/biosíntesis , Esteroide Hidroxilasas/genética , Luz Solar , Vitamina D3 24-Hidroxilasa
2.
Anticancer Res ; 30(7): 2667-72, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20682996

RESUMEN

BACKGROUND/AIM: Human ether à-go-go-1 (EAG1) potassium channels are promising anticancer targets. Calcitriol has antitumoural properties. This study investigated EAG1 regulation by calcitriol in normal and cancer cells. MATERIALS AND METHODS: Cancer cell lines from cervix, prostate, mammary gland, and normal placenta trophoblasts were cultured. Calcitriol was determined by HPLC. Gene and protein expression were assessed by real-time RT-PCR and western blot analysis, respectively. Calcitriol-synthesising enzyme CYP27B1 or vitamin D receptor (VDR), were transfected in cervical cancer SiHa cells. Cell proliferation was assayed with XTT. RESULTS: Calcitriol decreased EAG1 mRNA in all cell types, and EAG1 protein and proliferation in SiHa cells. VDR antagonist ZK-159222 prevented the calcitriol effect on EAG1 mRNA. CYP27B1-transfected cells produced more calcitriol and less EAG1 mRNA. EAG1 mRNA was more potently inhibited by calcitriol in VDR-transfected cells. CONCLUSION: EAG1 is a calcitriol target in normal and cancer cells and calcitriol is a potential therapy for cervical cancer.


Asunto(s)
Calcitriol/farmacología , Canales de Potasio Éter-A-Go-Go/biosíntesis , Neoplasias del Cuello Uterino/metabolismo , 25-Hidroxivitamina D3 1-alfa-Hidroxilasa/biosíntesis , 25-Hidroxivitamina D3 1-alfa-Hidroxilasa/genética , 25-Hidroxivitamina D3 1-alfa-Hidroxilasa/metabolismo , Neoplasias de la Mama/genética , Neoplasias de la Mama/metabolismo , Calcitriol/análogos & derivados , Calcitriol/metabolismo , Línea Celular Tumoral , Regulación hacia Abajo/efectos de los fármacos , Canales de Potasio Éter-A-Go-Go/genética , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Células HeLa , Humanos , Masculino , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/metabolismo , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptores de Calcitriol/antagonistas & inhibidores , Receptores de Calcitriol/biosíntesis , Receptores de Calcitriol/genética , Receptores de Calcitriol/metabolismo , Transfección , Neoplasias del Cuello Uterino/tratamiento farmacológico , Neoplasias del Cuello Uterino/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA